相关实验视频
Updated: Jun 30, 2025

08:02
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
18.4K
纳斯法-1通过核因子-κB (NF-κB) p65信号通路缓解高氧诱导的支气管肺功能失调 (BPD)
Li Zhang1, Zhang Zhuo2, Lijuan Chen3
1Department of Anesthesiology, Luzhou People's Hospital, Luzhou, China.
Journal of biochemical and molecular toxicology
|March 21, 2024
概括
纳斯法-1通过减少炎症和氧化应激,有效地治疗新生儿的支气管肺功能障碍症 (BPD). 这种为这种慢性呼吸道疾病提供了有前途的治疗策略.
科学领域:
- 新生儿医学 新生儿医学
- 呼吸系统生理学 呼吸系统生理学
- 分子生物学分子生物学
背景情况:
- 支气管肺功能障碍症 (BPD) 是新生儿的一种严重的慢性呼吸道疾病.
- 目前对BPD的治疗方法有限,这凸显了对新型治疗方法的需求.
- BPD的发病包括炎症和氧化应激 (OS).
研究的目的:
- 为了研究纳斯法廷-1对BPD的治疗潜力.
- 在新生儿BPD小鼠模型中评估Nesfatin-1对炎症和OS的影响.
主要方法:
- 新生小鼠被暴露在高氧中以诱导BPD.
- 鼠每天接受内内注射纳斯法-1.
- 鼠类II型上皮细胞 (AECII) 暴露于高氧,并用Nesfatin-1进行治疗.
- 肺组织和支气管洗液 (BALF) 分析了炎症标志物,氧化应激指标 (MDA,SOD) 和蛋白质含量.
- 评估了核因子-kappa B (NF-κB) 信号激活.
主要成果:
- 纳斯法廷-1治疗减轻了老鼠BPD相关的肺损伤标志物,包括RAC值,肺湿/干重量比和BALF蛋白.
- 纳斯法廷-1显著降低了BALF和暴露于高氧化的AECII中的促炎性细胞因子释放.
- 纳斯法-1通过降低甲 (MDA) 和增加超氧化物脱酶 (SOD) 活性来减轻氧化应激.
- 在动物模型和细胞培养中,Nesfatin-1抑制了NF-κB信号通路的激活.
结论:
- 纳斯法-1在缓解高氧诱导的BPD方面显示出显著的治疗疗效.
- 纳斯法-1的抗炎和抗氧化作用是通过抑制NF-κB信号通路进行介导的.
- 涅斯法廷-1代表了管理BPD的潜在新型治疗剂.
更多相关视频
09:17Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
18.1K
09:12Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
Published on: November 14, 2018
7.9K
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K